Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
about
Targeting the innate immune system as immunotherapy for acute myeloid leukemiaSynthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaquesBroad-Spectrum Drugs Against Viral AgentsToll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine developmentToll-like receptor agonists: are they good adjuvants?TLR-based immune adjuvants.Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.Trial Watch: Experimental Toll-like receptor agonists for cancer therapyDual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells.Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy.Differential Induction of Immunogenic Cell Death and Interferon Expression in Cancer Cells by Structured ssRNAs.Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections.
P2860
Q27015876-D40122CF-5440-4620-B4B0-791019312C6DQ27317212-FD11F0E2-E296-41D4-AD8A-A071B9E9E2F0Q27487859-F7A548FF-E4F4-46DF-B304-7CAA3F1EE89EQ31152190-2C51E5D6-C49F-467A-AF6D-A4B8D2EDCF4CQ33850508-977E63CB-9515-44BB-8430-FEBF798F6490Q34067537-95059590-F420-4AFC-9CBE-946ACA858937Q34400322-FD29B31D-725C-4622-9BBD-0B92E0833A63Q35167156-24B32F64-65A6-476C-9E62-15467832DE7CQ36194849-4899BE61-9229-4136-8214-9C37B84D6A47Q36916277-79557CC2-730C-47E4-9428-F9C441C97E70Q37626826-7A963592-84C7-4F2C-BC82-CEAECA2E4F37Q47236265-90301BB5-149A-47BA-96F8-6AC734D22211Q53382317-A20EBAE9-899C-4FB1-ADA5-135D56044311Q55379440-1C81E483-3C53-496F-8D64-20C2B251FDEB
P2860
Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
description
1985 nî lūn-bûn
@nan
1985 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Phase II trial of a complex po ...... Children's Cancer Study Group.
@ast
Phase II trial of a complex po ...... Children's Cancer Study Group.
@en
type
label
Phase II trial of a complex po ...... Children's Cancer Study Group.
@ast
Phase II trial of a complex po ...... Children's Cancer Study Group.
@en
prefLabel
Phase II trial of a complex po ...... Children's Cancer Study Group.
@ast
Phase II trial of a complex po ...... Children's Cancer Study Group.
@en
P2093
P1433
P1476
Phase II trial of a complex po ...... Children's Cancer Study Group
@en
P2093
P304
P407
P433
P577
1985-11-01T00:00:00Z